Drug Shortage Report for APO-SERTRALINE

Last updated on 2018-06-12 History
Report ID 40377
Drug Identification Number 02238281
Brand name APO-SERTRALINE
Common or Proper name SERTRALINE
Company Name APOTEX INC
Active Ingredient(s) SERTRALINE
Strength(s) 50MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 BTL
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-19
Estimated end date 2018-06-29
Actual end date 2018-06-11
Shortage status Resolved
Updated date 2018-06-12
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-02-21 English Compare
v2 2018-02-21 French Compare
v3 2018-04-16 English Compare
v4 2018-04-16 French Compare
v5 2018-06-07 English Compare
v6 2018-06-07 French Compare
v7 2018-06-12 English Compare
v8 2018-06-12 French Compare